| Host: | Mouse | 
| Applications: | IHC/WB | 
| Reactivity: | Human | 
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. | 
| Short Description : | Mouse monoclonal antibody anti-Keratin, type I cytoskeletal 13 (400-458 aa) is suitable for use in Immunohistochemistry and Western Blot research applications. | 
| Clonality : | Monoclonal | 
| Clone ID : | ABT057 | 
| Conjugation: | Unconjugated | 
| Isotype: | IgG1k | 
| Formulation: | Liquid in PBS pH7.2, 0.03% Proclin 300, with stabilizing protein. | 
| Purification: | The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen. | 
| Dilution Range: | IHC-P 1:200-400WB 500-1000 | 
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. | 
| Gene Symbol: | KRT13 | 
| Gene ID: | 3860 | 
| Uniprot ID: | K1C13_HUMAN | 
| Immunogen Region: | 400-458 aa | 
| Specificity: | The antibody can specifically recognize human CK13 protein. In western blotting of A431 cell lysate, the antibody can label a 50 kDa band corresponding to CK13. | 
| Immunogen: | Synthesized peptide derived from the human Cytokeratin 13 at the amino acid range 400-458 | 
| Post Translational Modifications | O-glycosylated.glycans consist of single N-acetylglucosamine residues. | 
| Function | Type 1 keratin (Probable). Maintains postnatal tongue mucosal cell homeostasis and tissue organization in response to mechanical stress, potentially via regulation of the G1/S phase cyclins CCNE1 and CCNE2. | 
| Protein Name | Keratin - Type I Cytoskeletal 13Cytokeratin-13Ck-13Keratin-13K13 | 
| Database Links | Reactome: R-HSA-6805567Reactome: R-HSA-6809371 | 
| Alternative Antibody Names | Anti-Keratin - Type I Cytoskeletal 13 antibodyAnti-Cytokeratin-13 antibodyAnti-Ck-13 antibodyAnti-Keratin-13 antibodyAnti-K13 antibodyAnti-KRT13 antibody | 
Information sourced from Uniprot.org
 
 
                     
                     
                       
                    

 
             
             
             
            